{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:59:40Z","timestamp":1791896380595,"version":"4.3.4"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Oxford National Institute of Health Research in UK, Musculoskeletal Biomedical Reseacrh Unit"},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust (GB)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009756","name":"Sarcoma UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009756","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bone Cancer Research Trust (UK)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s12016-015-8523-6","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T05:36:49Z","timestamp":1447738609000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases"],"prefix":"10.1007","volume":"51","author":[{"given":"A.","family":"Sabokbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Athanasou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"8523_CR1","first-page":"337","volume":"24","author":"HJ Knowles","year":"2009","unstructured":"Knowles HJ, Athanasou NA (2009) Canonical & non-canonical pathways of osteoclast formation. Histol Histopathol 24:337\u2013346","journal-title":"Histol Histopathol"},{"key":"8523_CR2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00256-011-1180-9","volume":"40","author":"NA Athanasou","year":"2011","unstructured":"Athanasou NA (2011) The osteoclast\u2014what\u2019s new? Skelet Radiol 40:1137\u20131140","journal-title":"Skelet Radiol"},{"key":"8523_CR3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","volume":"106","author":"HM Massey","year":"1999","unstructured":"Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106:167\u2013170","journal-title":"Br J Haematol"},{"key":"8523_CR4","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/endo.137.9.8756585","volume":"137","author":"Y Fujikawa","year":"1996","unstructured":"Fujikawa Y, Quinn JM, Sabokbar A, McGee JO\u2019D, Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058\u20134060","journal-title":"Endocrinology"},{"key":"8523_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00003086-199309000-00002","volume":"294","author":"DG Walker","year":"1993","unstructured":"Walker DG (1993) Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Clin Orthop Relat Res 294:4\u20136","journal-title":"Clin Orthop Relat Res"},{"key":"8523_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A","volume":"72","author":"J Faust","year":"1999","unstructured":"Faust J, Lacey DL, Hunt P et al (1999) Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem 72:67\u201380","journal-title":"J Cell Biochem"},{"key":"8523_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165\u2013176","journal-title":"Cell"},{"key":"8523_CR8","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N et al (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci U S A 95:3597\u20133602","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8523_CR9","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","volume":"274","author":"L Lum","year":"1999","unstructured":"Lum L, Wong BR, Josien R et al (1999) Evidence for a role of a tumour necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274:13613\u201313618","journal-title":"J Biol Chem"},{"key":"8523_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong YY, Yoshida H, Sarosi I et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315\u2013323","journal-title":"Nature"},{"key":"8523_CR11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1006\/bbrc.2001.6251","volume":"290","author":"R Kitazawa","year":"2002","unstructured":"Kitazawa R, Kitazawa S (2002) Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem Biophys Res Commun 290:650\u2013655","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR12","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","volume":"139","author":"NJ Horwood","year":"1998","unstructured":"Horwood NJ, Elliott J, Martin TJ, Gillespie MT (1998) Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743\u20134746","journal-title":"Endocrinology"},{"key":"8523_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","volume":"25","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S (1999) Interleukin-1beta and tumour necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255\u2013259","journal-title":"Bone"},{"key":"8523_CR14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S8756-3282(01)00404-5","volume":"28","author":"GJ Atkins","year":"2001","unstructured":"Atkins GJ, Bouralexis S, Haynes DR et al (2001) Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 28:370\u2013377","journal-title":"Bone"},{"key":"8523_CR15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","volume":"188","author":"K Fuller","year":"1998","unstructured":"Fuller K, Wong B, Fox S, Choi Y, Chambers TJ (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997\u20131001","journal-title":"J Exp Med"},{"key":"8523_CR16","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ et al (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 97:1566\u20131571","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8523_CR17","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: the OPG\/RANKL\/RANK system. Endocrinology 142:5050\u20135055","journal-title":"Endocrinology"},{"key":"8523_CR18","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","volume":"97","author":"N Kim","year":"2000","unstructured":"Kim N, Odgren PR, Kim DK, Marks SC Jr, Choi Y (2000) Diverse roles of the tumour necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci U S A 97:10905\u201310910","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"8523_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/03008200390181753","volume":"44","author":"PR Odgren","year":"2003","unstructured":"Odgren PR, Kim N, MacKay CA, Mason-Savas A, Choi Y, Marks SC Jr (2003) The role of RANKL (TRANCE\/TNFSF11), a tumour necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res 44(Suppl 1):264\u2013271","journal-title":"Connect Tissue Res"},{"key":"8523_CR20","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412\u20132424","journal-title":"Genes Dev"},{"key":"8523_CR21","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","volume":"141","author":"N Udagawa","year":"2000","unstructured":"Udagawa N, Takahashi N, Yasuda H et al (2000) Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478\u20133484","journal-title":"Endocrinology"},{"key":"8523_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1410195","volume":"141","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC (1999) Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur J Endocrinol 141:195\u2013210","journal-title":"Eur J Endocrinol"},{"key":"8523_CR23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","volume":"247","author":"A Mizuno","year":"1998","unstructured":"Mizuno A, Amizuka N, Irie K et al (1998) Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin. Biochem Biophys Res Commun 247:610\u2013615","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","volume":"12","author":"N Bucay","year":"1998","unstructured":"Bucay N, Sarosi I, Dunstan CR et al (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260\u20131268","journal-title":"Genes Dev"},{"issue":"12","key":"8523_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"2006","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006(12):17\u201325","journal-title":"Trends Mol Med"},{"key":"8523_CR26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","volume":"13","author":"MA Lomaga","year":"1999","unstructured":"Lomaga MA, Yeh WC, Sarosi I et al (1999) TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalling. Genes Dev 13:1015\u20131024","journal-title":"Genes Dev"},{"key":"8523_CR27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1359\/JBMR.041225","volume":"20","author":"K Kanazawa","year":"2000","unstructured":"Kanazawa K, Kudo A (2000) TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. J Bone Miner Res 20:840\u2013847","journal-title":"J Bone Miner Res"},{"key":"8523_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1359\/jbmr.2003.18.3.443","volume":"18","author":"K Kanazawa","year":"2003","unstructured":"Kanazawa K, Azuma Y, Nakano H, Kudo A (2003) TRAF5 functions in both RANKL- and TNF alpha-induced osteoclastogenesis. J Bone Miner Res 18:443\u2013450","journal-title":"J Bone Miner Res"},{"key":"8523_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(95)00153-Z","volume":"361","author":"I Nakamura","year":"1995","unstructured":"Nakamura I, Takahashi N, Sasaki T et al (1995) A specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption. FEBS Lett 361:79\u201384","journal-title":"FEBS Lett"},{"key":"8523_CR30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","volume":"3","author":"V Iotsova","year":"1997","unstructured":"Iotsova V, Caama\u00f1o J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285\u20131289","journal-title":"Nat Med"},{"key":"8523_CR31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693\u2013702","journal-title":"Cell"},{"key":"8523_CR32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nm752","volume":"8","author":"S Takeshita","year":"2002","unstructured":"Takeshita S, Namba N, Zhao J et al (2002) SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat Med 8:943\u2013949","journal-title":"Nat Med"},{"key":"8523_CR33","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"JP David","year":"2002","unstructured":"David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF (2002) JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci 115:4317\u20134325","journal-title":"J Cell Sci"},{"key":"8523_CR34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200308155","volume":"164","author":"L Kenner","year":"2004","unstructured":"Kenner L, Hoebertz A, Beil FT et al (2004) Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164:613\u2013623","journal-title":"J Cell Biol"},{"issue":"Suppl 2","key":"8523_CR35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.61.suppl_2.ii40","volume":"61","author":"EF Wagner","year":"2002","unstructured":"Wagner EF (2002) Functions of AP1 (Fos\/Jun) in bone development. Ann Rheum Dis 61(Suppl 2):40\u201342","journal-title":"Ann Rheum Dis"},{"key":"8523_CR36","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1101\/gad.187900","volume":"14","author":"A Fleischmann","year":"2000","unstructured":"Fleischmann A, Hafezi F, Elliott C, Rem\u00e9 CE, R\u00fcther U, Wagner EF (2000) Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev 14:2695\u20132700","journal-title":"Genes Dev"},{"key":"8523_CR37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jcb.240550311","volume":"55","author":"R Felix","year":"1994","unstructured":"Felix R, Hofstetter W, Wetterwald A, Cecchini MG, Fleisch H (1994) Role of colony-stimulating factor-1 in bone metabolism. J Cell Biochem 55:340\u2013349","journal-title":"J Cell Biochem"},{"key":"8523_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00062752-199805000-00006","volume":"5","author":"AM Flanagan","year":"1998","unstructured":"Flanagan AM, Lader CS (1998) Update on the biologic effects of macrophage colony-stimulating factor. Curr Opin Hematol 5:181\u2013185","journal-title":"Curr Opin Hematol"},{"key":"8523_CR39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0925-5710(98)00010-3","volume":"67","author":"K Motoyoshi","year":"1998","unstructured":"Motoyoshi K (1998) Biological activities and clinical application of M-CSF. Int J Hematol 67:109\u2013122","journal-title":"Int J Hematol"},{"key":"8523_CR40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0092-8674(85)80047-7","volume":"41","author":"CJ Sherr","year":"1985","unstructured":"Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665\u2013676","journal-title":"Cell"},{"key":"8523_CR41","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/endo-127-5-2592","volume":"127","author":"R Felix","year":"1990","unstructured":"Felix R, Cecchini MG, Fleisch H (1990) Macrophage colony stimulating factor restores in vivo bone resorption in the op\/op osteopetrotic mouse. Endocrinology 127:2592\u20132594","journal-title":"Endocrinology"},{"key":"8523_CR42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H Yoshida","year":"1990","unstructured":"Yoshida H, Hayashi S, Kunisada T et al (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442\u2013444","journal-title":"Nature"},{"issue":"2","key":"8523_CR43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cyto.2011.11.014","volume":"57","author":"G Mabilleau","year":"2012","unstructured":"Mabilleau G, Pascaretti-Grizon F, Basle MF, Chappard D (2012) Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha\/IL-1 or LIGHT. Cytokine 57(2):294\u2013299","journal-title":"Cytokine"},{"key":"8523_CR44","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481\u20131488","journal-title":"J Clin Invest"},{"key":"8523_CR45","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","volume":"275","author":"Y Azuma","year":"2000","unstructured":"Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A (2000) Tumour necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858\u20134864","journal-title":"J Biol Chem"},{"key":"8523_CR46","doi-asserted-by":"crossref","first-page":"13964","DOI":"10.1074\/jbc.M601553200","volume":"281","author":"C Bossen","year":"2006","unstructured":"Bossen C, Ingold K, Tardivel A et al (2006) Interactions of tumour necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 281:13964\u201313971","journal-title":"J Biol Chem"},{"key":"8523_CR47","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.21821","volume":"54","author":"JR Edwards","year":"2006","unstructured":"Edwards JR, Sun SG, Locklin R et al (2006) LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum 54:1451\u20131462","journal-title":"Arthritis Rheum"},{"key":"8523_CR48","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/eji.200939069","volume":"39","author":"C Pasero","year":"2009","unstructured":"Pasero C, Barbarat B, Just-Landi S et al (2009) A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumour cell death and chemokine production. Eur J Immunol 39:2502\u20132514","journal-title":"Eur J Immunol"},{"key":"8523_CR49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","volume":"15","author":"GJ Atkins","year":"2000","unstructured":"Atkins GJ, Haynes DR, Graves SE et al (2000) Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 15:640\u2013649","journal-title":"J Bone Miner Res"},{"key":"8523_CR50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.59.1.26","volume":"59","author":"I Itonaga","year":"2000","unstructured":"Itonaga I, Sabokbar A, Murray DW, Athanasou NA (2000) Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann Rheum Dis 59:26\u201331","journal-title":"Ann Rheum Dis"},{"key":"8523_CR51","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1177\/00220345010800061101","volume":"80","author":"T Tervahartiala","year":"2001","unstructured":"Tervahartiala T, Koski H, Xu JW, H\u00e4yrinen-Immonen R, Hietanen J, Sorsa T, Konttinen YT (2001) Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 80:1535\u20131539","journal-title":"J Dent Res"},{"key":"8523_CR52","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","volume":"118","author":"F Brennan","year":"2008","unstructured":"Brennan F, McInnes IB (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537\u20133545","journal-title":"J Clin Invest"},{"key":"8523_CR53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/path.1891","volume":"208","author":"IE Adamopoulos","year":"2006","unstructured":"Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA (2006) Synovial fluid macrophages are capable for osteoclast formation and resorption. J Pathol 208:35\u201343","journal-title":"J Pathol"},{"key":"8523_CR54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.1780340908","volume":"34","author":"CQ Chu","year":"1991","unstructured":"Chu CQ, Field M, Feldmann M, Maini RN (1991) Localisation of tumour necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 34:1125\u20131132","journal-title":"Arthritis Rheum"},{"key":"8523_CR55","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.4049\/jimmunol.167.11.6330","volume":"167","author":"RB Shaikh","year":"2001","unstructured":"Shaikh RB, Santee S, Granger SW et al (2001) Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167:6330\u20136337","journal-title":"J Immunol"},{"key":"8523_CR56","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.3518059","volume":"232","author":"EL Hohmann","year":"1986","unstructured":"Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gebhard RL (1986) Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 232:868\u2013871","journal-title":"Science"},{"key":"8523_CR57","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/jor.20269","volume":"24","author":"L Wang","year":"2006","unstructured":"Wang L, Zhou S, Liu B et al (2006) Locally applied nerve growth factor enhances bone consolidation in a rabbit model of mandibular distraction osteogenesis. J Orthop Res 24:2238\u20132245","journal-title":"J Orthop Res"},{"key":"8523_CR58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jemt.10121","volume":"58","author":"A Togari","year":"2002","unstructured":"Togari A (2002) Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58:77\u201384","journal-title":"Microsc Res Tech"},{"key":"8523_CR59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0304-4165(88)90127-4","volume":"966","author":"S Mohan","year":"1988","unstructured":"Mohan S, Jennings JC, Linkhart TA, Baylink DJ (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta 966:44\u201355","journal-title":"Biochim Biophys Acta"},{"key":"8523_CR60","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bone.2010.12.023","volume":"48","author":"F Hemingway","year":"2011","unstructured":"Hemingway F, Taylor R, Knowles HJ, Athanasou NA (2011) RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 48:938\u2013944","journal-title":"Bone"},{"key":"8523_CR61","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1172\/JCI38716","volume":"119","author":"Z Yao","year":"2009","unstructured":"Yao Z, Xing L, Boyce BF (2009) NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest 119:3024\u20133034","journal-title":"J Clin Invest"},{"key":"8523_CR62","first-page":"27","volume":"15","author":"M Centrella","year":"1994","unstructured":"Centrella M, Horowitz MC, Wozney JM, McCarthy TL (1994) Transforming growth factor-gene family members and bone. Endocr Rev 15:27\u201339","journal-title":"Endocr Rev"},{"key":"8523_CR63","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI113647","volume":"82","author":"J Pfeilschifter","year":"1998","unstructured":"Pfeilschifter J, Seyedin SM, Mundy GR (1998) Transforming growth factor beta inhibits bone resorption in fetal rat long bone culture. J Clin Invest 82:680\u2013685","journal-title":"J Clin Invest"},{"key":"8523_CR64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/endo.141.1.7285","volume":"141","author":"M Inoue","year":"2006","unstructured":"Inoue M, Ross FP, Erdmann JM, Abu-Amer Y, Wei S, Teitelbaum SL (2006) Tumour necrosis factor alpha regulates alpha(v)beta5 integrin expression by osteoclast precursors in vitro and in vivo. Endocrinology 141:284\u2013290","journal-title":"Endocrinology"},{"key":"8523_CR65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","volume":"198","author":"O Kudo","year":"2002","unstructured":"Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA (2002) Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation. J Pathol 198:220\u2013227","journal-title":"J Pathol"},{"key":"8523_CR66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2004.02.001","volume":"26","author":"T Ma","year":"2004","unstructured":"Ma T, Miyanishi K, Suen A et al (2004) Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-\u03b1. Cytokine 26:138\u2013144","journal-title":"Cytokine"},{"key":"8523_CR67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115:282\u2013290","journal-title":"J Clin Invest"},{"issue":"2","key":"8523_CR68","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","volume":"170","author":"SL Teitelbaum","year":"2007","unstructured":"Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170(2):427\u2013435","journal-title":"Am J Pathol"},{"issue":"5","key":"8523_CR69","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1074\/jbc.M110.150300","volume":"286","author":"G Mabilleau","year":"2011","unstructured":"Mabilleau G, Chappard D, Sabokbar A (2011) Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 286(5):3242\u20133249","journal-title":"J Biol Chem"},{"issue":"4","key":"8523_CR70","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.30201","volume":"63","author":"DJ Mahoney","year":"2011","unstructured":"Mahoney DJ, Swales C, Athanasou NA et al (2011) TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. Arthritis Rheum 63(4):1034\u20131043","journal-title":"Arthritis Rheum"},{"key":"8523_CR71","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","volume":"143","author":"K Fuller","year":"2002","unstructured":"Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNF\u03b1 potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108\u20131118","journal-title":"Endocrinology"},{"key":"8523_CR72","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/en.2005-1340","volume":"147","author":"K Fuller","year":"2006","unstructured":"Fuller K, Kirstein B, Chambers TJ (2006) Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147:1979\u20131985","journal-title":"Endocrinology"},{"key":"8523_CR73","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1346.056","volume":"1068","author":"J Iqbal","year":"2006","unstructured":"Iqbal J (2006) Does TNF have anti osteoclastogenic actions? Ann N Y Acad Sci 1068:234\u2013239","journal-title":"Ann N Y Acad Sci"},{"key":"8523_CR74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","volume":"8","author":"DN Mauri","year":"1998","unstructured":"Mauri DN, Ebner R, Montgomery RI et al (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin are ligands for herpesvirus entry mediator. Immunity 8:21\u201330","journal-title":"Immunity"},{"key":"8523_CR75","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.4049\/jimmunol.164.8.4105","volume":"164","author":"K Tamada","year":"2000","unstructured":"Tamada K, Shimozaki K, Chapoval AI et al (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164:4105\u20134110","journal-title":"J Immunol"},{"key":"8523_CR76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81363-X","volume":"87","author":"RI Montgomery","year":"1996","unstructured":"Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of TNF\/NGF receptor family. Cell 87:427\u2013436","journal-title":"Cell"},{"key":"8523_CR77","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI3492","volume":"102","author":"Y Zhai","year":"1998","unstructured":"Zhai Y, Guo R, Hsu TL et al (1998) LIGHT, a novel ligand for lymphotoxin receptor and TR2\/HVEM, induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102:1142\u20131151","journal-title":"J Clin Invest"},{"key":"8523_CR78","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbrc.2008.04.184","volume":"371","author":"SK Heo","year":"2008","unstructured":"Heo SK, Yun HJ, Park WH, Park SD (2008) NADPH oxidase activation is required for migration by LIGHT in human monocytes. Biochem Biophys Res Commun 371:834\u2013840","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0105-2896.2004.00206.x","volume":"202","author":"K Schneider","year":"2004","unstructured":"Schneider K, Potter KG, Ware CF (2004) Lymphotoxin and LIGHT signaling pathways and target genes. Immunol Rev 202:49\u201366","journal-title":"Immunol Rev"},{"key":"8523_CR80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11373-005-1360-5","volume":"12","author":"TH Chang","year":"2005","unstructured":"Chang TH, Hsieh SL, Chao Y, Chou YC, Lin WW (2005) Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells. J Biomed Sci 12:363\u2013375","journal-title":"J Biomed Sci"},{"key":"8523_CR81","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/art.22493","volume":"56","author":"YM Kang","year":"2007","unstructured":"Kang YM, Kim SY, Kang JH et al (2007) LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum 56:1106\u20131117","journal-title":"Arthritis Rheum"},{"key":"8523_CR82","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.20012088","volume":"195","author":"Q Ye","year":"2002","unstructured":"Ye Q, Fraser CC, Gao W et al (2002) Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med 195:795\u2013800","journal-title":"J Exp Med"},{"key":"8523_CR83","doi-asserted-by":"crossref","first-page":"14307","DOI":"10.1074\/jbc.275.19.14307","volume":"275","author":"IA Rooney","year":"2000","unstructured":"Rooney IA, Butrovich KD, Glass AA et al (2000) The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 275:14307\u201314315","journal-title":"J Biol Chem"},{"key":"8523_CR84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1359-6101(03)00031-5","volume":"14","author":"SW Granger","year":"2003","unstructured":"Granger SW, Rickert S (2003) LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 14:289\u2013296","journal-title":"Cytokine Growth Factor Rev"},{"key":"8523_CR85","doi-asserted-by":"crossref","first-page":"14029","DOI":"10.1074\/jbc.272.22.14029","volume":"272","author":"SA Marsters","year":"1997","unstructured":"Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272:14029\u201314032","journal-title":"J Biol Chem"},{"key":"8523_CR86","doi-asserted-by":"crossref","unstructured":"Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW (2004) Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte\/macrophage lineage precursor cells. Cell Death Differ. Suppl 1:S97-107","DOI":"10.1038\/sj.cdd.4401403"},{"key":"8523_CR87","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yexmp.2013.01.003","volume":"94","author":"F Hemingway","year":"2013","unstructured":"Hemingway F, Kashima TG, Knowles HJ, Athanasou NA (2013) Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. Exp Mol Pathol 94:380\u2013385","journal-title":"Exp Mol Pathol"},{"key":"8523_CR88","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1101\/gad.12.18.2821","volume":"12","author":"RH Arch","year":"1998","unstructured":"Arch RH, Gedrich RW, Thompson CB (1998) Tumour necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev 12:2821\u20132830","journal-title":"Genes Dev"},{"key":"8523_CR89","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","volume":"188","author":"M Hahne","year":"1998","unstructured":"Hahne M, Kataoka T, Schroter M et al (1998) APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188:1185\u20131190","journal-title":"J Exp Med"},{"key":"8523_CR90","first-page":"1021","volume":"60","author":"K Kelly","year":"2000","unstructured":"Kelly K, Manos E, Jensen G, Nadauld L, Jones DA (2000) APRIL\/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60:1021\u20131027","journal-title":"Cancer Res"},{"key":"8523_CR91","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","volume":"189","author":"P Schneider","year":"1999","unstructured":"Schneider P, MacKay F, Steiner V et al (1999) BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747\u20131756","journal-title":"J Exp Med"},{"key":"8523_CR92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1615\/CritRevEukaryotGeneExpr.v9.i1.30","volume":"9","author":"LF Bonewald","year":"1995","unstructured":"Bonewald LF (1995) Regulation and regulatory activities of transforming growth factor beta. Crit Rev Eukaryot Gene Exp 9:33\u201344","journal-title":"Crit Rev Eukaryot Gene Exp"},{"key":"8523_CR93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S8756-3282(01)00432-X","volume":"28","author":"HM Massey","year":"2002","unstructured":"Massey HM, Scopes J, Horton MA, Flanagan AM (2002) Transforming growth factor-beta stimulates the osteoclast-forming potential of peripheral blood haematopoietic precursors in a lymphocyte-rich microenvironment. Bone 28:577\u2013582","journal-title":"Bone"},{"key":"8523_CR94","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jbmr.5650100619","volume":"10","author":"J Beaudreuil","year":"1995","unstructured":"Beaudreuil J, Mbalaviele G, Cohen-Solal M, Morieux C, de Vernejoul MC, Orcel P (1995) Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rat. J Bone Miner Res 10:971\u2013977","journal-title":"J Bone Miner Res"},{"key":"8523_CR95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2013.07.023","volume":"57","author":"K Ota","year":"2013","unstructured":"Ota K, Quint P, Weivoda MM et al (2013) Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. Bone 57:68\u201375","journal-title":"Bone"},{"key":"8523_CR96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2003.08.008","volume":"34","author":"I Itonaga","year":"2004","unstructured":"Itonaga I, Sabokbar A, Sun SG et al (2004) Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. Bone 34:57\u201364","journal-title":"Bone"},{"key":"8523_CR97","doi-asserted-by":"crossref","first-page":"27091","DOI":"10.1074\/jbc.273.42.27091","volume":"273","author":"H Takai","year":"1998","unstructured":"Takai H, Kanematsu M, Yano K et al (1998) Transforming growth factor-beta stimulates the production of osteoprotegerin\/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273:27091\u201327096","journal-title":"J Biol Chem"},{"key":"8523_CR98","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","volume":"145","author":"Y Ishimi","year":"1990","unstructured":"Ishimi Y, Miyaura C, Jin CH et al (1990) IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297\u20133303","journal-title":"J Immunol"},{"key":"8523_CR99","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"T Tamura","year":"1993","unstructured":"Tamura T, Udagawa N, Takahashi N et al (1993) Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 90:11924\u201311928","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8523_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","volume":"32","author":"O Kudo","year":"2003","unstructured":"Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32:1\u20137","journal-title":"Bone"},{"key":"8523_CR101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI115584","volume":"89","author":"GD Roodman","year":"1992","unstructured":"Roodman GD, Kurihara N, Ohsaki Y et al (1992) Interleukin 6. A potential autocrine\/paracrine factor in Paget\u2019s disease of bone. J Clin Invest 89:46\u201352","journal-title":"J Clin Invest"},{"key":"8523_CR102","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","volume":"33","author":"MS Bendre","year":"2003","unstructured":"Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ (2003) Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone 33:28\u201337","journal-title":"Bone"},{"key":"8523_CR103","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","volume":"65","author":"MS Bendre","year":"2005","unstructured":"Bendre MS, Margulies AG, Walser B et al (2005) Tumour-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 65:11001\u201311009","journal-title":"Cancer Res"},{"key":"8523_CR104","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S8756-3282(00)00281-7","volume":"26","author":"K Asaumi","year":"2000","unstructured":"Asaumi K, Nakanishi T, Asahara H, Inoue H, Takigawa M (2000) Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone 26:625\u2013633","journal-title":"Bone"},{"key":"8523_CR105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00297230","volume":"260","author":"SR Frenkel","year":"1990","unstructured":"Frenkel SR, Guerra LA, Mitchell OG, Singh IJ (1990) Nerve growth factor in skeletal tissues of the embryonic chick. Cell Tissue Res 260:507\u2013511","journal-title":"Cell Tissue Res"},{"key":"8523_CR106","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/17453679808999059","volume":"69","author":"B Grills","year":"1998","unstructured":"Grills B, Schuijers J (1998) Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop Scand 69:415\u2013419","journal-title":"Acta Orthop Scand"},{"key":"8523_CR107","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0306-4522(93)90588-7","volume":"54","author":"M Hukkanen","year":"1993","unstructured":"Hukkanen M, Konttinen Y, Santavirta S et al (1993) Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 54:969\u2013979","journal-title":"Neuroscience"},{"key":"8523_CR108","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S8756-3282(99)00215-X","volume":"25","author":"CM Serre","year":"1990","unstructured":"Serre CM, Farlay D, Delmas PD, Chenu C (1990) Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 25:623\u2013629","journal-title":"Bone"},{"key":"8523_CR109","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0026-0495(90)90154-5","volume":"39","author":"CM Bautista","year":"1990","unstructured":"Bautista CM, Mohan S, Baylink DJ (1990) Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism 39:96\u2013100","journal-title":"Metabolism"},{"key":"8523_CR110","doi-asserted-by":"crossref","first-page":"93S","DOI":"10.1016\/8756-3282(95)00186-H","volume":"17","author":"JM Hayden","year":"1995","unstructured":"Hayden JM, Mohan S, Baylink DJ (1995) The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S\u201398S","journal-title":"Bone"},{"key":"8523_CR111","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/endo.136.1.7828521","volume":"136","author":"PA Hill","year":"1995","unstructured":"Hill PA, Reynolds JJ, Meikle MC (1995) Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136:124\u2013131","journal-title":"Endocrinology"},{"key":"8523_CR112","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2005.01.042","volume":"328","author":"H Fukuoka","year":"2005","unstructured":"Fukuoka H, Aoyama M, Miyazawa K, Asai K, Goto S (2005) Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells. Biochem Biophys Res Commun 328:885\u2013894","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR113","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/endo.131.3.1505451","volume":"131","author":"H Mochizuki","year":"1992","unstructured":"Mochizuki H, Hakeda Y, Wakatsuki N et al (1992) Insulin-like growth factor-I supports formation and activation of osteoclasts. Endocrinology 131:1075\u20131080","journal-title":"Endocrinology"},{"key":"8523_CR114","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbrc.2008.11.083","volume":"378","author":"K Nakao","year":"2009","unstructured":"Nakao K, Aoyama M, Fukuoka H, Fujita M, Miyazawa K, Asai K, Goto S (2009) IGF II modulates the microenvironment for osteoclastogenesis. Biochem Biophys Res Commun 378:462\u2013466","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR115","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","volume":"277","author":"M Zhang","year":"2002","unstructured":"Zhang M, Xuan S, Bouxsein ML et al (2002) Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signalling in bone matrix mineralization. J Biol Chem 277:44005\u201344012","journal-title":"J Biol Chem"},{"key":"8523_CR116","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1359\/jbmr.060610","volume":"21","author":"Y Wang","year":"2006","unstructured":"Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21:1350\u20131358","journal-title":"J Bone Miner Res"},{"key":"8523_CR117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S8756-3282(97)00224-X","volume":"22","author":"J Guicheux","year":"1998","unstructured":"Guicheux J, Heymann D, Rousselle AV et al (1998) Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. Bone 22:25\u201331","journal-title":"Bone"},{"key":"8523_CR118","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0006-291X(05)80249-9","volume":"176","author":"CM Bautista","year":"1991","unstructured":"Bautista CM, Baylink DJ, Mohan S (1991) Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756\u2013763","journal-title":"Biochem Biophys Res Commun"},{"key":"8523_CR119","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/8756-3282(94)00040-9","volume":"16","author":"J Middleton","year":"1995","unstructured":"Middleton J, Arnott N, Walsh S, Beresford J (1995) Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 16:287\u2013293","journal-title":"Bone"},{"key":"8523_CR120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-4644(19980701)70:1<121::AID-JCB12>3.0.CO;2-S","volume":"70","author":"MH Zheng","year":"1998","unstructured":"Zheng MH, Fan Y, Smith A, Wysocki S, Papadimitriou JM, Wood DJ (1998) Gene expression of monocyte chemoattractant protein-1 in giant cell tumors of bone osteoclastoma: possible involvement in CD68+ macrophage-like cell migration. J Cell Biochem 70:121\u2013129","journal-title":"J Cell Biochem"},{"key":"8523_CR121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00022744-200106000-00010","volume":"9","author":"A Franchi","year":"2001","unstructured":"Franchi A, Benvenuti S, Masi L et al (2001) TGF-beta isoform and receptor expression in giant cell tumor and giant cell lesions of bone. Appl Immunohistochem Mol Morphol 9:170\u2013175","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"8523_CR122","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00003086-199601000-00027","volume":"322","author":"J Middleton","year":"1996","unstructured":"Middleton J, Arnott N, Walsh S, Beresford J (1996) The expression of mRNA for insulin-like growth factors and their receptor in giant cell tumors of human bone. Clin Orthop 322:224\u2013231","journal-title":"Clin Orthop"},{"key":"8523_CR123","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1189\/jlb.1105655","volume":"80","author":"P Mhawech-Fauceglia","year":"2006","unstructured":"Mhawech-Fauceglia P, Kaya G, Sauter G et al (2006) The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol 80:697\u2013704","journal-title":"J Leukoc Biol"},{"key":"8523_CR124","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.bjc.6603774","volume":"96","author":"YS Lau","year":"2007","unstructured":"Lau YS, Adamopoulos IE, Sabokbar A, Giele H, Gibbons CL, Athanasou NA (2007) Cellular and humoral mechanisms of osteoclast formation in Ewing\u2019s sarcoma. Br J Cancer 96:1716\u20131722","journal-title":"Br J Cancer"},{"key":"8523_CR125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10549-006-9438-y","volume":"105","author":"YS Lau","year":"2007","unstructured":"Lau YS, Danks L, Sun SG et al (2007) RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer. Breast Cancer Res Treat 105:7\u201316","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"8523_CR126","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.bjc.6603103","volume":"94","author":"YS Lau","year":"2006","unstructured":"Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, Athanasou NA (2006) Malignant melanoma and bone resorption. Br J Cancer 94(10):1496\u20131503","journal-title":"Br J Cancer"},{"key":"8523_CR127","doi-asserted-by":"crossref","unstructured":"Oranger A, Carbone C, Izzo M, Grano M. (2013) Cellular mechanisms of multiple myeloma bone disease. Clin Dev Immunol. 289458","DOI":"10.1155\/2013\/289458"},{"key":"8523_CR128","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.18632\/oncotarget.2633","volume":"5","author":"G Brunetti","year":"2014","unstructured":"Brunetti G, Rizzi R, Oranger A et al (2014) LIGHT\/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. Oncotarget 5:12950\u201312967","journal-title":"Oncotarget"},{"key":"8523_CR129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.11005\/jbm.2014.21.2.85","volume":"21","author":"DL Galson","year":"2014","unstructured":"Galson DL, Roodman GD (2014) Pathobiology of Paget\u2019s Disease of Bone. J Bone Metab 21:85\u201398","journal-title":"J Bone Metab"},{"key":"8523_CR130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.989","volume":"195","author":"T Hirayama","year":"2014","unstructured":"Hirayama T, Sabokbar A, Itonaga I, Watt-Smith S, Athanasou NA (2014) Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195:624\u2013630","journal-title":"J Pathol"},{"key":"8523_CR131","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1158\/1078-0432.CCR-07-0753","volume":"13","author":"P Neri","year":"2007","unstructured":"Neri P, Kumar S, Fulciniti MT et al (2007) Neutralizing B-cell activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model. Clin Cancer Res 13:5903\u20135909","journal-title":"Clin Cancer Res"},{"key":"8523_CR132","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","volume":"106","author":"J Moreaux","year":"2005","unstructured":"Moreaux J, Cremer FW, Reme T et al (2005) The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106:1021\u20131030","journal-title":"Blood"},{"key":"8523_CR133","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2404228","volume":"20","author":"M Abe","year":"2006","unstructured":"Abe M, Kido S, Hiasa M et al (2006) BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma. Leukemia 20:1313\u20131315","journal-title":"Leukemia"},{"key":"8523_CR134","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0736-0266(02)00106-7","volume":"21","author":"A Sabokbar","year":"2003","unstructured":"Sabokbar A, Kudo O, Athanasou NA (2003) Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. J Orthop Res 21:73\u201380","journal-title":"J Orthop Res"},{"key":"8523_CR135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/art.22493","volume":"56","author":"YM Yang","year":"2007","unstructured":"Yang YM, Kim SY, Kang JH et al (2007) LIGHT up regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum 56:1106\u20131107","journal-title":"Arthritis Rheum"},{"key":"8523_CR136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4049\/jimmunol.171.1.115","volume":"171","author":"RA Fava","year":"2003","unstructured":"Fava RA, Notidis E, Hunt J et al (2003) A role for the lymphotoxin\/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 171:115\u2013116","journal-title":"J Immunol"},{"key":"8523_CR137","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2008.02965.x","volume":"128","author":"S Ishida","year":"2009","unstructured":"Ishida S, Yamane S, Nakano S et al (2009) The interaction of monocytes with rheumatoid synovial cells is a key step in LIGHT-mediated inflammatory bone destruction. Immunology 128:315\u2013324","journal-title":"Immunology"},{"key":"8523_CR138","first-page":"960","volume":"35","author":"S Ishida","year":"2003","unstructured":"Ishida S, Yamane S, Ochi T et al (2003) LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor. J Rheumatol 35:960\u2013968","journal-title":"J Rheumatol"},{"key":"8523_CR139","unstructured":"Pierer M, Brentano F, Rethage J. et al. (2009) The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis"},{"key":"8523_CR140","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4049\/jimmunol.1001159","volume":"185","author":"TC Cheung","year":"2010","unstructured":"Cheung TC, Coppieters K, Sanjo H et al (2010) Polymorphic variants of LIGHT (TNF superfamily \u221214) alter receptor avidity and bioavailability. J Immunol 185:1949\u20131958","journal-title":"J Immunol"},{"key":"8523_CR141","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J et al (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome. Ann Rheum Dis 62:168\u2013171","journal-title":"Ann Rheum Dis"},{"key":"8523_CR142","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","volume":"1050","author":"JO Pers","year":"2005","unstructured":"Pers JO, Daridon C, Devauchelle V et al (2005) BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 1050:34\u201339","journal-title":"Ann N Y Acad Sci"},{"key":"8523_CR143","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaut.2012.06.001","volume":"39","author":"TJ Dickerson","year":"2012","unstructured":"Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE (2012) Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. J Autoimmun 39:369\u2013376","journal-title":"J Autoimmun"},{"key":"8523_CR144","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","volume":"187","author":"IE Adamopoulos","year":"2011","unstructured":"Adamopoulos IE, Tessmer M, Chao CC et al (2011) IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol 187:951\u2013959","journal-title":"J Immunol"},{"key":"8523_CR145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrrheum.2014.198","volume":"11","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos IE, Mellins ED (2015) Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nat Rev Rheumatol 11:189\u2013194","journal-title":"Nat Rev Rheumatol"},{"key":"8523_CR146","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.1401013","volume":"194","author":"HS Shin","year":"2015","unstructured":"Shin HS, Sarin R, Dixit N, Wu J, Gershwin E, Bowman EP, Adamopoulos IE (2015) Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J Immunol 194:316\u2013324","journal-title":"J Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8523-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8523-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8523-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T21:47:19Z","timestamp":1692136039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8523-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["8523"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8523-6","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}